🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Performance and Safety of the ANTALGEEK® Thess Monitoring Medical Device in the Outpatient Management of Acute Pain and Postoperative Recovery

RecruitingNAAges 18 Years - anyAllCentre Hospitalier Universitaire de Nīmes
NCT07680998 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Acute postoperative pain (APOP) is a major public health problem, affecting nearly 10 million patients in France each year. Effective analgesic therapy in the first postoperative week is a key factor in reducing early postoperative morbidity and mortality. Poorly controlled APOP is a major risk factor for chronic postoperative pain. In France today, more and more patients undergo surgical procedures as outpatients. The challenge is to manage postoperative pain in the homes of patients who have undergone increasingly complex surgical procedures, either after outpatient surgery or after a prompt return home as part of an Enhanced Recovery After Surgery (ERAS) protocol. In outpatient surgery, postoperative pain management requires new strategies and/or organizational approaches to ensure high-quality pain management from the very start. The principle of analgesia for acute postoperative pai

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients eligible for outpatient surgery. * Patients undergoing surgery likely to result in moderate to severe pain. * Patients available for a 3-month follow-up. * Patients who have provided their free and informed consent. * Patients who have signed the consent form. * Patients enrolled in or covered by a health insurance plan. Exclusion Criteria: * Patients participating in an interventional RIPH study involving a drug or classified as Category 1. * Patients in an exclusion period determined by another study. * Patients under judicial protection, guardianship, or conservatorship. * Patients unable to express consent. * Patient for whom it is impossible to provide informed information. * Pregnant, laboring, or breastfeeding patients.
💊

What it tests

  • Post-operative follow-up using the Thess Telemonitoring device in conjunction with the ANTALGEEK® protocol
📍

Where

1 site
Nimes University Hospital
Nîmes, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy